Logo

American Heart Association

  50
  0


Final ID:

Precision therapy for Genetic HCM: Cardiac Myosin Inhibitors

  • Kawana, Masataka  ( STANFORD UNIVERSITY , Stanford , California , United States )
  • Wilsbacher, Lisa  ( NORTHWESTERN UNIVERSITY , Evanston, IL , Illinois , United States )
  • Wheeler, Matthew  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Author Disclosures:
    Masataka Kawana: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Research Funding (PI or named investigator):FANCL Corp.:Active (exists now) ; Advisor:Holosis Health:Active (exists now) ; Advisor:Cardiac RSK3 Inhibitors, LLC:Active (exists now) | Lisa Wilsbacher: DO NOT have relevant financial relationships | Matthew Wheeler: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

What A Busy Cardiologist Needs to Know About Genetics

Friday, 11/07/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Pharmacogenomics - where does it help me?

Luzum Jasmine, Wells Quinn, Pereira Naveen

What is the risk of genetic testing for my patient?

Jordan Elizabeth, Reuter Chloe, Murray Brittney

More abstracts from these authors:
Discussant: MUSIC-HFpEF

Kawana Masataka

Wrap -Up

Chahal Choudhary Anwar A., Wilsbacher Lisa

You have to be authorized to contact abstract author. Please, Login
Not Available